Noval, Baby Girl .

HRN: 26-61-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2025
AMPICILLIN 250MG (VIAL)
01/28/2025
02/03/2025
IV
100 Mg
Q12H
PSNB
Waiting Final Action 
01/28/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/28/2025
02/03/2025
IV
25 Mg
Q24H
Preterm Newborn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: